Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia Healthcare Press.

Press releases published on May 27, 2026

Sionna Therapeutics to Participate in Upcoming June 2026 Investor Conferences
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
Collegium to Participate in 2026 Jefferies Global Healthcare Conference
Galectin Therapeutics Presents New EASL 2026 Oral and Poster Analyses Demonstrating Belapectin’s Potential to Modify Disease Progression in Advanced MASH Cirrhosis
ViroMissile IDOV-Safe Phase 1 Data to Be Presented at the 2026 ASCO Annual Meeting
Avalyn to Participate in the Jefferies Global Healthcare Conference
Annexon to Participate in Upcoming June Investor Conferences
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty
Join BioVie’s Exclusive Live Investor Webinar and Q and A Session on June 2
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
New REDUCE-IT® Analysis Presented at the European Atherosclerosis Society (EAS) Congress 2026 Suggests Risk-Weighted ApoB May Improve Identification of Residual Cardiovascular Risk in Statin-Treated Patients with Hypertriglyceridemia
4DMT to Participate in Upcoming Investor Conferences
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis
Mineralys Therapeutics to Participate in the Jefferies Global Healthcare Conference
Noom Brings the Lab to the Living Room: New At-Home Biomarkers Test Kit Enables Members to See Exactly How GLP-1s and Healthy Habits Are Transforming Their Health
Erasca to Present at the Jefferies Global Healthcare Conference
Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics
Mesa Labs Announces Fourth Quarter and Fiscal Year 2026 Results
Callio Therapeutics to Present Phase 1 Trial Design of CLIO-8221, Novel Dual-Payload ADC, at ASCO 2026
Health Coalition to provide details re. giant march Thursday to demand Doug Ford stop his unprecedented privatization of our public hospital services

Share this page:

Sign up for:

Virginia Healthcare Press

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.